AD (n = 1,133) | Control (n = 1,159) | P-value | |
---|---|---|---|
Age at examination (years) (mean ± SD) | 79.94 ± 8.12 | 74.48 ± 6.29 | |
Age at onset (years) (mean ± SD) | 75.01 ± 8.00 | 0.078a | |
Gender, n (%) | |||
Male | 464 (41.0) | 518 (44.7) | 0.070 |
Female | 669 (59.0) | 641 (55.3) | |
MMSE (mean ± SD) | 10.06 ± 3.82 | 28.26 ± 1.08 | < 0.001 |
ApoE ϵ4 status, n (%) | |||
ApoE ϵ4 carrier | 315 (27.8) | 158 (13.6) | < 0.001 |
ApoE ϵ4 noncarrier | 818 (72.2) | 1,001 (86.4) |